Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Waeber

Showing results (391-400 of 458) with videos related to

Pageof 46
Sort By:
RNA (New York, N.Y.)|July 31, 2025
Bacterial/archaeal protein-only RNase P: complementation in <i>Escherichia coli</i> uncovers coevolution of protein-only RNase P and precursor tRNA structures in <i>Aquifex aeolicus</i>Swetlana Davydov, Nadine B Waeber, Markus Goessringer, et al.
The American Journal of Physiology|June 1, 1995
Effects of chronic NO synthase inhibition in rats on renin-angiotensin system and sympathetic nervous systemA Zanchi, N C Schaad, M C Osterheld, et al.
Hypertension (Dallas, Tex. : 1979)|November 1, 1990
Determinants of angiotensin II generation during converting enzyme inhibitionL Juillerat, J Nussberger, J Ménard, et al.
Journal of Cardiovascular Pharmacology|April 1, 1997
SC-52458, an orally active angiotensin II-receptor antagonist: inhibition of blood pressure response to angiotensin II challenges and pharmacokinetics in normal volunteersM Hagmann, J Nussberger, R B Naudin, et al.
The American Journal of Physiology|January 1, 1984
Does vasopressin sustain blood pressure of normally hydrated healthy volunteers?J P Bussien, B Waeber, J Nussberger, et al.
Pflugers Archiv : European Journal of Physiology|November 3, 2001
Cardiovascular effects of fentanyl in conscious ratsF Baechtold, C Cavadas, D Gasser, et al.
Journal of Cardiovascular Pharmacology|February 1, 1990
Reactive hyperreninemia is a major determinant of plasma angiotensin II during ACE inhibitionV Mooser, J Nussberger, L Juillerat, et al.
Peptides|January 1, 1994
Localization of neuropeptide Y and its C-terminal flanking peptide in human renal tissueE Grouzmann, G Alvarez-Bolado, C Meyer, et al.
Journal of Cardiovascular Pharmacology|September 1, 1994
Value of different clinical and biochemical correlates to assess angiotensin converting enzyme inhibitionE Delacrétaz, J Nussberger, K Püchler, et al.
Diabetes & Metabolism|December 17, 2005
Increased plasma levels of N-terminal brain natriuretic peptide (NT-proBNP) in type 2 diabetic patients with vascular complicationsS Beer, S Golay, D Bardy, et al.
Pageof 46

Showing results (391-400 of 458) with videos related to

Sort By:
Pageof 46
RNA (New York, N.Y.)|July 31, 2025
Bacterial/archaeal protein-only RNase P: complementation in <i>Escherichia coli</i> uncovers coevolution of protein-only RNase P and precursor tRNA structures in <i>Aquifex aeolicus</i>Swetlana Davydov, Nadine B Waeber, Markus Goessringer, et al.
The American Journal of Physiology|June 1, 1995
Effects of chronic NO synthase inhibition in rats on renin-angiotensin system and sympathetic nervous systemA Zanchi, N C Schaad, M C Osterheld, et al.
Hypertension (Dallas, Tex. : 1979)|November 1, 1990
Determinants of angiotensin II generation during converting enzyme inhibitionL Juillerat, J Nussberger, J Ménard, et al.
Journal of Cardiovascular Pharmacology|April 1, 1997
SC-52458, an orally active angiotensin II-receptor antagonist: inhibition of blood pressure response to angiotensin II challenges and pharmacokinetics in normal volunteersM Hagmann, J Nussberger, R B Naudin, et al.
The American Journal of Physiology|January 1, 1984
Does vasopressin sustain blood pressure of normally hydrated healthy volunteers?J P Bussien, B Waeber, J Nussberger, et al.
Pflugers Archiv : European Journal of Physiology|November 3, 2001
Cardiovascular effects of fentanyl in conscious ratsF Baechtold, C Cavadas, D Gasser, et al.
Journal of Cardiovascular Pharmacology|February 1, 1990
Reactive hyperreninemia is a major determinant of plasma angiotensin II during ACE inhibitionV Mooser, J Nussberger, L Juillerat, et al.
Peptides|January 1, 1994
Localization of neuropeptide Y and its C-terminal flanking peptide in human renal tissueE Grouzmann, G Alvarez-Bolado, C Meyer, et al.
Journal of Cardiovascular Pharmacology|September 1, 1994
Value of different clinical and biochemical correlates to assess angiotensin converting enzyme inhibitionE Delacrétaz, J Nussberger, K Püchler, et al.
Diabetes & Metabolism|December 17, 2005
Increased plasma levels of N-terminal brain natriuretic peptide (NT-proBNP) in type 2 diabetic patients with vascular complicationsS Beer, S Golay, D Bardy, et al.
Pageof 46